Announcements Trials

Browse Landscape

Phase

Status

Completed 24 Terminated 7 Withdrawn 1 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 54 Squamous Cell Carcinoma of Head and Neck 29 Urinary Bladder Neoplasms 17 Head and Neck Neoplasms 17 Lung Neoplasms 16 Oropharyngeal Neoplasms 13 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Nasopharyngeal Carcinoma 11 Carcinoma 10 Small Cell Lung Carcinoma 9 Carcinoma, Transitional Cell 8 Uterine Cervical Neoplasms 7 Pancreatic Neoplasms 7 Ovarian Neoplasms 7 Neoplasm Metastasis 7 Carcinoma, Squamous Cell 7 Breast Neoplasms 7 Triple Negative Breast Neoplasms 6 Recurrence 6 Neoplasms 6 Mouth Neoplasms 6 Melanoma 6 Gallbladder Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Esophageal Neoplasms 6 Mesothelioma, Malignant 5 Medulloblastoma 5 Laryngeal Neoplasms 5 Colorectal Neoplasms 5 Cholangiocarcinoma 5

Interventions

Radiotherapy 11 pembrolizumab 10 Nivolumab 10 Doxorubicin 10 Magnetic Resonance Spectroscopy 9 Specimen Handling 8 Ipilimumab 7 Cyclophosphamide 7 Biopsy 7 X-Rays 6 Radiation 5 Phantoms, Imaging 5 Ifosfamide 5 talimogene laherparepvec 4 cabozantinib 4 Nuclear Medicine Department, Hospital 4 Irinotecan 4 tazemetostat 3 selpercatinib 3 pazopanib 3 liposomal doxorubicin 3 Temozolomide 3 Etoposide 3 ulixertinib 2 tislelizumab 2 tipifarnib 2 palbociclib 2 larotrectinib 2 ivosidenib 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Sarcoma × Cisplatin × Clear all

NCT00470223 2025-06-08

OS2006

UNICANCER

Phase 3 Active not recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡